Jay C Jha1,2, Vicki Thallas-Bonke1, Claudine Banal1, Stephen P Gray1, Bryna S M Chow1, Georg Ramm3, Susan E Quaggin4, Mark E Cooper1,2, Harald H H W Schmidt5, Karin A Jandeleit-Dahm6,7. 1. Diabetes Complications Division, Baker IDI Heart & Diabetes Research Institute, PO Box 6492, St Kilda Rd, Melbourne, VIC, 8008, Australia. 2. Department of Medicine, Monash University, Melbourne, VIC, Australia. 3. Monash Micro-imaging, Monash University, Melbourne, VIC, Australia. 4. Robert H. Lurie Medical Research Center, Chicago, IL, USA. 5. Department of Pharmacology, Cardiovascular Research Institute Maastricht (CARIM), Faculty of Medicine, Health & Life Science, Maastricht University, Maastricht, the Netherlands. 6. Diabetes Complications Division, Baker IDI Heart & Diabetes Research Institute, PO Box 6492, St Kilda Rd, Melbourne, VIC, 8008, Australia. karin.jandeleit-dahm@bakeridi.edu.au. 7. Department of Medicine, Monash University, Melbourne, VIC, Australia. karin.jandeleit-dahm@bakeridi.edu.au.
Abstract
AIMS/HYPOTHESIS: Changes in podocyte morphology and function are associated with albuminuria and progression of diabetic nephropathy. NADPH oxidase 4 (NOX4) is the main source of reactive oxygen species (ROS) in the kidney and Nox4 is upregulated in podocytes in response to high glucose. We assessed the role of NOX4-derived ROS in podocytes in vivo in a model of diabetic nephropathy using a podocyte-specific NOX4-deficient mouse, with a major focus on the development of albuminuria and ultra-glomerular structural damage. METHODS: Streptozotocin-induced diabetes-associated changes in renal structure and function were studied in male floxedNox4 and podocyte-specific, NOX4 knockout (podNox4KO) mice. We assessed albuminuria, glomerular extracellular matrix accumulation and glomerulosclerosis, and markers of ROS and inflammation, as well as glomerular basement membrane thickness, effacement of podocytes and expression of the podocyte-specific protein nephrin. RESULTS: Podocyte-specific Nox4 deletion in streptozotocin-induced diabetic mice attenuated albuminuria in association with reduced vascular endothelial growth factor (VEGF) expression and prevention of the diabetes-induced reduction in nephrin expression. In addition, podocyte-specific Nox4 deletion reduced glomerular accumulation of collagen IV and fibronectin, glomerulosclerosis and mesangial expansion, as well as glomerular basement membrane thickness. Furthermore, diabetes-induced increases in renal ROS, glomerular monocyte chemoattractant protein-1 (MCP-1) and protein kinase C alpha (PKC-α) were attenuated in podocyte-specific NOX4-deficient mice. CONCLUSIONS/ INTERPRETATION: Collectively, this study shows the deleterious effect of Nox4 expression in podocytes by promoting podocytopathy in association with albuminuria and extracellular matrix accumulation in experimental diabetes, emphasising the role of NOX4 as a target for new renoprotective agents.
AIMS/HYPOTHESIS: Changes in podocyte morphology and function are associated with albuminuria and progression of diabetic nephropathy. NADPH oxidase 4 (NOX4) is the main source of reactive oxygen species (ROS) in the kidney and Nox4 is upregulated in podocytes in response to high glucose. We assessed the role of NOX4-derived ROS in podocytes in vivo in a model of diabetic nephropathy using a podocyte-specific NOX4-deficient mouse, with a major focus on the development of albuminuria and ultra-glomerular structural damage. METHODS:Streptozotocin-induced diabetes-associated changes in renal structure and function were studied in male floxedNox4 and podocyte-specific, NOX4 knockout (podNox4KO) mice. We assessed albuminuria, glomerular extracellular matrix accumulation and glomerulosclerosis, and markers of ROS and inflammation, as well as glomerular basement membrane thickness, effacement of podocytes and expression of the podocyte-specific protein nephrin. RESULTS: Podocyte-specific Nox4 deletion in streptozotocin-induced diabeticmiceattenuated albuminuria in association with reduced vascular endothelial growth factor (VEGF) expression and prevention of the diabetes-induced reduction in nephrin expression. In addition, podocyte-specific Nox4 deletion reduced glomerular accumulation of collagen IV and fibronectin, glomerulosclerosis and mesangial expansion, as well as glomerular basement membrane thickness. Furthermore, diabetes-induced increases in renal ROS, glomerular monocyte chemoattractant protein-1 (MCP-1) and protein kinase C alpha (PKC-α) were attenuated in podocyte-specific NOX4-deficient mice. CONCLUSIONS/ INTERPRETATION: Collectively, this study shows the deleterious effect of Nox4 expression in podocytes by promoting podocytopathy in association with albuminuria and extracellular matrix accumulation in experimental diabetes, emphasising the role of NOX4 as a target for new renoprotective agents.
Authors: Kensuke Asaba; Akihiro Tojo; Maristela Lika Onozato; Atsuo Goto; Mark T Quinn; Toshiro Fujita; Christopher S Wilcox Journal: Kidney Int Date: 2005-05 Impact factor: 10.612
Authors: Sun Hee Sung; Fuad N Ziyadeh; Amy Wang; Petr E Pyagay; Yashpal S Kanwar; Sheldon Chen Journal: J Am Soc Nephrol Date: 2006-09-20 Impact factor: 10.121
Authors: Christine Koulis; Bryna S M Chow; Maria McKelvey; Ulrike M Steckelings; Thomas Unger; Vicki Thallas-Bonke; Merlin C Thomas; Mark E Cooper; Karin A Jandeleit-Dahm; Terri J Allen Journal: Hypertension Date: 2015-03-16 Impact factor: 10.190
Authors: Thijs W Cohen Tervaert; Antien L Mooyaart; Kerstin Amann; Arthur H Cohen; H Terence Cook; Cinthia B Drachenberg; Franco Ferrario; Agnes B Fogo; Mark Haas; Emile de Heer; Kensuke Joh; Laure H Noël; Jai Radhakrishnan; Surya V Seshan; Ingeborg M Bajema; Jan A Bruijn Journal: J Am Soc Nephrol Date: 2010-02-18 Impact factor: 10.121
Authors: Chet E Holterman; Jean-François Thibodeau; Chelsea Towaij; Alex Gutsol; Augusto C Montezano; Robin J Parks; Mark E Cooper; Rhian M Touyz; Christopher R J Kennedy Journal: J Am Soc Nephrol Date: 2013-11-21 Impact factor: 10.121
Authors: Jay C Jha; Aozhi Dai; Chet E Holterman; Mark E Cooper; Rhian M Touyz; Chris R Kennedy; Karin A M Jandeleit-Dahm Journal: Diabetologia Date: 2019-06-20 Impact factor: 10.122
Authors: Daria V Ilatovskaya; Gregory Blass; Oleg Palygin; Vladislav Levchenko; Tengis S Pavlov; Michael N Grzybowski; Kristen Winsor; Leonid S Shuyskiy; Aron M Geurts; Allen W Cowley; Lutz Birnbaumer; Alexander Staruschenko Journal: J Am Soc Nephrol Date: 2018-05-23 Impact factor: 10.121
Authors: Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm Journal: Antioxid Redox Signal Date: 2016-04-01 Impact factor: 8.401
Authors: Eoin P Brennan; Muthukumar Mohan; Aaron McClelland; Christos Tikellis; Mark Ziemann; Antony Kaspi; Stephen P Gray; Raelene Pickering; Sih Min Tan; Syed Tasadaque Ali-Shah; Patrick J Guiry; Assam El-Osta; Karin Jandeleit-Dahm; Mark E Cooper; Catherine Godson; Phillip Kantharidis Journal: J Am Soc Nephrol Date: 2018-02-28 Impact factor: 10.121
Authors: Jinhua Li; Yu Bo Yang Sun; Weiyi Chen; Jinjin Fan; Songhui Li; Xinli Qu; Qikang Chen; Riling Chen; Dajian Zhu; Jinfeng Zhang; Zhuguo Wu; Honggang Chi; Simon Crawford; Viola Oorschot; Victor G Puelles; Peter G Kerr; Yi Ren; Susan K Nilsson; Mark Christian; Huanwen Tang; Wei Chen; John F Bertram; David J Nikolic-Paterson; Xueqing Yu Journal: EMBO Rep Date: 2020-01-09 Impact factor: 8.807